Background. Plasmodium falciparum infection in pregnancy can lead to congenital malaria, which has detrimental health consequences for infants. Human immunodeficiency virus (HIV) might increase cord blood P. falciparum infection by decreasing maternal antimalarial-specific antibodies.
Transplacental transmission of Plasmodium falciparum from mother to fetus can lead to congenital malaria. Antenatal acquisition of infections has usually been described as a rare event of little clinical relevance in semiimmune individuals [1] , mostly occurring in low malaria transmission areas [2] . Rates of congenital malaria have been thought to be low due to protection conferred by the placental barrier and by the transfer of maternal antimalarial antibodies to the fetus [3] . However, congenital malaria has been suggested to contribute to preterm delivery, infant anemia, and neonatal mortality [3] [4] [5] [6] and may have a profound effect on susceptibility to malaria in childhood by affecting the development of antimalarial immunity in utero [7] .
Congenital malaria is usually defined as the presence of asexual forms of malaria parasites in the peripheral blood of the newborn within the first 7 days of life or in the cord blood [2] . However, recent work in conjunction with molecular diagnostics detecting submicroscopic infections suggests that vertical transmission of P. falciparum malaria has been underestimated in areas of high malaria endemicity and may vary between ,1% and 33% [2, 8] . The clinical relevance of submicroscopic P. falciparum infections and the risk factors for congenital malaria are not clearly known. It has been reported that congenital malaria infection is higher in primigravidae, in women with placental malaria infection [9] [10] [11] , and in women with high placental parasite density [3] or severe placental inflammation [12] . It has also been suggested that pathological changes in the placenta or higher parasite densities associated with human immunodeficiency virus (HIV) infection [13] could increase the risk of vertical transmission of P. falciparum. However, studies have reported contradictory results on the impact that HIV infection may have on congenital malaria [11, [14] [15] [16] , and none of these studies has analyzed the contribution of HIV-associated impairment of P. falciparum-specific immunity [17] [18] [19] [20] .
The objective of this study was to assess whether maternal HIV infection was a risk factor for cord blood infection with P. falciparum in Mozambican pregnant women and to investigate potential mechanisms of action. We hypothesized that HIV might increase cord blood P. falciparum infections by decreasing maternal antibody responses against P. falciparum. To address this, we detected cord blood infections by quantitative polymerase chain reaction (qPCR) among Mozambican women at delivery and assessed the effect of HIV infection, placental and peripheral malaria, and maternal P. falciparum-specific immunoglobulin levels on the risk of cord blood infections.
MATERIALS AND METHODS

Study Population
This study was integrated into a randomized, double-blind, placebo-controlled trial of 2-dose intermittent preventive treatment (IPTp) with sulphadoxine-pyrimethamine for malaria prevention in pregnancy (trial registration number: NCT00209781) conducted in Manhic xa, Mozambique, between 2003 and 2006 [21] . In this semirural area in southern Mozambique, malaria transmission is perennial with some seasonality, and P. falciparum is the predominant species. At the time of the study, malaria control in pregnancy relied exclusively on case management. Highly active antiretroviral therapy was not available and the women followed national policy on prevention of mother-to-child transmission of HIV infection. Mothers received nevirapine for self-administration at the onset of labor and for administration to the newborn within the first 72 hours of life [21] .
After providing written informed consent, pregnant women were given a long-lasting insecticide-treated net and were randomized to receive sulfadoxine-pyrimethamine or placebo. Women went through the voluntary counseling program for motherto-child prevention of HIV and were screened for HIV. Maternal HIV-1 status was determined with the Determine HIV-1/2 Rapid Test (Abbott Laboratories) and confirmed with the Unigold rapid test (Trinity Biotech). At delivery, peripheral and cord blood was collected into ethylenediaminetetraacetic acid vacutainers. The umbilical cord was clamped and cut before the placenta was released. Cord blood was collected by venipuncture with the needle pointing to the uterus. Peripheral blood of the mother was also extracted by venipuncture. Thick smears were prepared from the mother and the umbilical cord blood. Placental biopsies from the maternal side of the placenta were processed for histological examination [22] . Maternal hematocrit level was quantified in a microcapillary tube after centrifugation. Blood was centrifuged, and plasma was stored at 220°C. Peripheral, cord, and placental blood was collected onto filter papers (no. 903TM; Schleicher and Schuell).
A total of 1030 women were enrolled in the IPTp trial, of whom 870 women accepted HIV testing [21] . The current analysis was taken from the final 188 women enrolled in the randomized controlled trial using demographic and clinical data as well as samples from maternal, placental, and cord blood. The study was approved by the Mozambican National Bioethics Committee and the Hospital Clinic of Barcelona Ethics Review Committee.
P. falciparum Detection by Microscopy and qPCR
Thin and thick smears were Giemsa stained and examined for malarial parasites according to quality-control procedures [23] . DNA was extracted from blood drops of 50 lL onto filter paper with an ABIPrism 6700 Automated Nucleic Acid Work Station (Applied Biosystems) and finally resuspended in 200 lL of water. Five microliters of DNA samples (corresponding to 1.5 lL of blood) was screened for P. falciparum DNA by qPCR targeting the 18S ribosomal RNA gene, as described elsewhere [24] .
Measurement of Antibodies Against Merozoite Antigens and Parasite Lysate
Maternal plasma samples were tested by enzyme-linked immunosorbent assay for the presence of immunoglobulin G (IgG), immunoglobulin M (IgM), and IgG subclasses specific for the recombinant antigens merozoite surface protein 1 (MSP1 19 ; 19-kD fragment, 3D7) [25] , erythrocyte-binding antigen 175 (EBA175; region F2, Camp) [26] , and apical membrane antigen 1 (AMA1; full ectodomain, 3D7) [27] from the International Centre for Genetic Engineering and Biotechnology. As described previously [28] , 96-well microplates (Nunc Maxisorp) were coated overnight at 4°C with 200 ng of recombinant antigen per well diluted in 0.05 mol/L carbonate-bicarbonate buffer. After blocking with 2% bovine serum albumin, 100 lL of plasma diluted at 1:500 (for IgG and IgM) or 1:200 (for IgG subtypes) was tested in duplicate. Secondary peroxidase-conjugated antibodies were used as follows: goat anti-human IgG, 1:30 000; IgM, 1:2000 (Sigma); sheep anti-human IgG1, 1:6000; IgG2, 1:3000; IgG3, 1:6000; and IgG4, 1:3000 (The Binding Site). Reactions were developed as described elsewhere [28] , and optical density (OD) values were read at 492 nm.
To measure antibodies to P. falciparum lysate, the 3D7 and HB3 clones (provided by MR4) from a nonsynchronous culture at 5% parasitemia and 1% hematocrit levels were homogenized in phosphate-buffered saline by a minimum of 3 freeze-thawing steps. A lysate of uninfected red blood cells was used to determine nonspecific recognition. Coating was done with 50 lL of the erythrocyte extract, and plasma was added at a 1:6400 dilution for IgG and 1:1600 for IgG subclasses and IgM. Incubation of antibodies and development of the reaction were performed as described previously. Optical densities of uninfected lysate wells were subtracted from ODs of infected wells. A pool of plasma samples obtained from 15 Mozambican pregnant women of known high reactivity against P. falciparum antigens [28] was used to normalize the data from different assays by multiplying ODs in each experiment by the ratio between the value of the positive control set as reference (first experiment) and the value of the positive control in subsequent experiments.
Measurement of Antibodies Against the Surface of Infected Erythrocytes
Maternal plasma samples were tested by flow cytometry for recognition of P. falciparum antigens on the surface of erythrocytes infected by the chondroitin-sulfate A (CSA)-binding strain CS2 (MRA-96, MR4, American Type Culture Collection) and a non-CSA-binding isolate that was obtained from a Mozambican child and adapted to in vitro culture (MOZ2) [28] . Mature trophozoites at 1%-3% parasitemia levels were cryopreserved in multiple aliquots to minimize interassay variations. Parasites were thawed, resuspended at 1% hematocrit level, and incubated with test plasma at 1:20 dilution. Cell suspensions were sequentially incubated with polyclonal rabbit anti-human IgG (DakoCytomation) and Alexa Fluor donkey anti-rabbit IgG (Invitrogen) plus ethidium bromide. Reactivity against the surface of infected erythrocytes was expressed as the difference between the mean fluorescence intensity (MFI) of infected erythrocytes and the MFI of uninfected erythrocytes obtained in a Becton Dickinson FACSCalibur flow cytometer. A pool of plasma samples obtained from 15 Mozambican pregnant women was used to normalize the data from different assays as described previously.
Measurement of HIV RNA Levels and CD4 Counts
Plasma HIV RNA levels were measured using a reverse transcription PCR (Amplicor, Roche Monitor version 1.5) from cryopreserved samples. The lower limit of detection of the assay was 400 copies/mL. CD4 counting was performed after staining fresh whole blood samples with labeled antibodies specific for CD4, CD3, CD8, and CD45 in TruCount tubes (Becton Dickinson Biosciences).
Definitions and Statistical Methods
Pregnant women were classified into first-time mothers (primigravidae, PG) and those with at least 1 previous pregnancy (multigravidae, MG). Age was categorized as #20 years, 21-25 years, and .25 years. Maternal anemia was considered if the hematocrit level was ,33%. Peripheral, placental, and cord P. falciparum infection was defined as the presence of parasites detected by qPCR in peripheral, placental, and cord blood, respectively. Placental inflammation was defined as .5 inflammatory cells observed by histological examination in 10 high-power fields using 3400 magnification [29] . High antibody levels were defined as those plasma samples having an OD or MFI value above the median determined for each specific immunoglobulin [30, 31] . Parasite densities were compared between groups by Wilcoxon test. Logistic regression models were used to estimate the association of HIV and other clinical and immunological covariates with congenital P. falciparum infection. Multivariate models were adjusted for peripheral and placental infection, placental inflammation, parity, age, maternal anemia, and treatment group. Crude and adjusted logistic regression methods were used to evaluate the association between HIV and antibodies as well as the association between P. falciparum cord blood infections and antibodies. The final model for estimating associations with congenital P. falciparum infection included both clinical and immunological variables. For all logistic regression models, crude proportions and adjusted odds ratios (AORs) with their corresponding 95% confidence interval (CI) were computed. Statistical analysis was performed using Stata 10.0 (StataCorp).
RESULTS
Factors Associated With Cord Blood P. falciparum Infection
Of the 188 cord blood samples tested, 15 (8.0%; 95% CI, 4.5%-12.8%) were found to be positive for P. falciparum as determined by qPCR, whereas only 3 were positive by microscopy (1.6%; 95% CI, .3%-4.6%). The characteristics of the women at delivery according to cord blood malaria infection status are presented in Table 1 . Among the 188 placental samples assessed by histology, active infection (presence of P. falciparum parasite alone or in combination with malaria pigment) was found in 25 (13%) and past infection (presence of pigment in absence of parasite) in 72 (38%). One hundred thirty-three (71%) women were HIV-negative, and 55 (29%) were HIVpositive. The subset of 188 women included in this study and the 1030 women participating in the randomized trial were comparable in terms of IPTp with sulphadoxine-pyrimethamine received (53% 4 .0]; P 5 .57). Similarly, no difference was found in parity (P 5 1.00), age (P 5 .81), qPCR-detected peripheral (P 5 .73) and placental infection (P 5 .73) or placental histology (P 5 . Univariate logistic regression analysis showed that maternal HIV status, maternal anemia, and peripheral and placental P. falciparum infection detected by qPCR were significantly associated with a P. falciparum PCR-positive cord blood sample (Table 1) . Among the 2 women with cord blood infections in absence of placental infection, 1 had a qPCR-detected peripheral blood P. falciparum infection. No difference was found in qPCR parasite densities in placental samples by cord blood infection (P 5 .99) or by HIV-infection (P 5 .30). Multivariate logistic regression adjusted for maternal anemia, parity, age, peripheral and placental malaria, placental inflammation, and treatment group showed that only maternal HIV status and placental malaria remained independently associated with increased risk of cord blood P. falciparum infection (Table 1) .
Within the 52 HIV-positive women with viral load data available at delivery (3 data missing), standard defined high peripheral HIV RNA level (.10 5 copies/mL) at delivery did not appear to be associated with congenital P. falciparum infection by univariate logistic regression (OR, 2.6 [95% CI, . .66]; P 5 .31). Similarly, no association was found between high viral load and placental infection (P 5 .75) or peripheral infection in the mother (P 5 .66). HIV-positive women were not in stages of advanced immunosuppression as suggested by the median CD4 values for the 36 HIV-positive women with CD4 counts available (501 CD4 cells/lL; interquartile range, 381-681).
Impact of HIV on P. falciparum-Specific Antibody Levels
The odds of having high IgG specific for CS2 and parasite lysate, IgG1 for EBA175, and IgG2 for MSP1 were higher in HIVnegative women compared with HIV-positive women (Table 2) . Similarly, the analysis of antibody levels as continuous variable showed that women with HIV infection, compared with those without infection, had lower IgG for CS2, MOZ2, MSP1, and P. falciparum lysate, as well as lower IgM for MSP1, AMA1, and EBA175 ( Figure 1 ). Logistic regression analysis adjusted for maternal anemia, parity, age, peripheral and placental malaria, placental inflammation, and treatment group showed that women with high levels of IgG specific for CS2, EBA175, and parasite lysate, as well as those with high IgG1 specific for EBA175 and lysate, had a reduced risk of cord blood malaria infection (Table 3) . In order to evaluate whether HIV infection and P. falciparum malaria-specific antibody levels were independently associated with cord blood infections, a multivariate logistic regression model was constructed that included variables that were shown to be associated with cord blood malaria. The model included 2 clinical variables (placental malaria and maternal HIV status) and the 5 immunological variables shown to be associated with cord blood infections (high/low maternal IgG against CS2, EBA175, and lysate, and IgG1 against EBA175 and parasite lysate). Placental malaria was found to be associated with increased risk of 
DISCUSSION
This study shows for the first time that pregnant women with low levels of IgG specific for CS2, EBA175, and P. falciparum lysate have an increased risk of cord blood malaria infection. It also confirms that maternal HIV infection is associated with a higher risk of cord blood infection [11, 14, 16] and an overall reduction of P. falciparum-specific antibody levels [17] [18] [19] . The multivariate adjusted model demonstrates that placental malaria and low levels of CS2-specific IgG and P. falciparum lysate-specific IgG1, but not HIV, are independent risk factors for cord blood malaria infection, thus suggesting that HIV might indirectly increase cord blood malaria infection by decreasing levels of potentially protective P. falciparum-specific antibodies. The 8.0% prevalence of P. falciparum cord blood infections by qPCR observed in this study falls within the range of prevalences observed in other areas of sub-Saharan Africa (1%-33%) [2, 32] . As previously reported [10, 16, 33] , placental malaria is associated with an increased risk of cord blood malaria infection, reinforcing the concept of vertical transmission of P. falciparum through micro-transfusions of placental blood into the fetal circulation cells as well as direct penetration of the parasite through the choriamniotic villi [2, 34] . One pregnant woman had a cord blood infection in the absence of placental and peripheral infection at delivery, suggesting the transplacental passage of a maternal P. falciparum infection that was resolved before delivery. In this study, placental parasite density was not found to be associated with cord blood malaria infection or HIV infection. An earlier study found that maternal HIV infection increased placental parasite density and was associated with increased congenital malaria infection [16] . The authors found that this relationship was stronger in an area of intense malaria transmission compared with a holoendemic area, thus suggesting that the relationships between maternal HIV status, placental parasite density, and congenital malaria infection may be highly dependent on the P. falciparum transmission intensity.
This study also confirms that HIV infection can impair the P. falciparum-specific antibody responses in pregnant women [17-19, 35, 36] . The antigen-specificity of the antibodies affected appear to differ between studies, with some pointing to an HIV-induced decline in antibodies specific for the erythrocyte surface of placental isolates [18, 36] , pediatric isolates [35] , or merozoite proteins such as AMA1 and MSP1 [18, 19] . In this study, HIV infection was associated with lower IgG levels specific for a wide range of parasite antigens, including whole parasite, merozoites, and proteins expressed on the surface of infected erythrocytes from a CSA-binding line and a pediatric isolate. Results of this study are in accordance with other reports showing that maternal HIV infection decreases antibodies specific for Haemophilus influenzae type b and pneumococcus [37] . These observations point toward a general suppression of antibody responses by HIV infection [35] , possibly through impairment of memory B cells mediating long-term humoral immunity [38, 39] , rather than a phenomenon specifically associated with immune responses against P. falciparum placental type parasites [18, 36] . Similar to IgG, IgM levels were lower among HIV-positive women compared with HIV-negative women, suggesting that decreased B-cell responses during HIV infection might also occur in IgM-producing cells.
To our knowledge, the current work is the first to show a relationship between HIV, low levels of maternal P. falciparumspecific antibodies, and increased risk of cord blood malaria infection. In particular, IgGs recognizing CS2 and IgG1 specific for EBA175 and P. falciparum lysate were the immunoglobulins found to be associated with a reduced risk of cord blood infection, suggesting that these antibodies may prevent parasites from crossing the placental barrier or restrict parasite growth once the parasites reach fetal blood. Of importance, these antibodies were found to be reduced in HIV-infected women compared with those without infection. Also, HIV was associated with cord blood infections in the univariate analysis but failed to reach statistical significance once the analysis was adjusted by these antibody responses. Overall, these observations led us to conclude that HIV infection may reduce the ability of pregnant women to control vertical transmission of malaria by impairing maternal antibody responses.
This study has several limitations. First, the study assessed cord blood malaria infection determined by qPCR. This is not the classical definition of congenital malaria and, whereas microscopic cord blood infections have been suggested to contribute to poor health outcomes [3] [4] [5] [6] , little is known about the impact of submicroscopic infection. However, even low-density infections during fetal development may contribute to the acquisition in utero of a phenotype tolerant to P. falciparum blood-stage antigens, ultimately increasing susceptibility to malaria [7] . Second, the admixture of maternal and fetal blood at delivery cannot be discarded. However, previous studies have suggested this mixing to be low or absent on the basis of discordant levels of parasite genotypes, placental alkaline phosphatase, and immunoglobulin E levels [11, 40] . Third, it was not possible to assess whether immunosuppression was associated with cord blood infections because CD4 counts were not available for all the HIV-infected women. Fourth, the presence of malaria infection in pregnant women was determined at delivery and does not account for malaria infections occurring earlier during gestation, which could also contribute to cord blood infections. Finally, the observational approach of the study describes potential associations but cannot infer causal relationships.
In summary, this study shows that placental malaria infection and low antibodies against CSA-binding parasites and other P. falciparum antigens present in the parasite lysate are independent risk factors for congenital malaria infection. Although prevalence of cord blood infections determined by qPCR was higher in HIV-infected women compared with uninfected women, HIV was not found to be independently associated with cord blood infections in a multivariate analysis including immunological variables. This observation, together with the reduction of antibodies associated to HIV infection, suggests that HIV impairment of P. falciparum-specific maternal immunity may increase the risk of congenital malaria infection. This is of great public health relevance because increasing prevalence of HIV infection in Mozambique and other parts of southern Africa [41, 42] , together with declines in malaria transmission in these areas [43, 44] , may translate into a reduction of antimalarial immunity in pregnant women. This impaired immunity may in turn increase the risk of cord blood infection among those pregnant women who become infected with P. falciparum and increase preterm delivery, infant anemia, and neonatal mortality Abbrevations: AOR, adjusted odds ratio; CI, confidence interval; Ig, immunoglobulin. a Results are expressed as proportion of mothers with high-level antibodies. Antibody levels are categorized as high (above median) or low (below median).
b P value from univariate logistic regression.
c P value from multivariate logistic regression. AOR adjusted for human immunodeficiency virus status, parity, maternal age, intermittent preventive treatment during pregnancy, maternal anemia, placental inflammation, and peripheral and placental malaria. [3] [4] [5] [6] . Further studies will be important in establishing the clinical impact of qPCR-detected cord blood infections and in determining whether malaria screening of infants from HIV-infected mothers would allow the identification and treatment of infants who are at risk for congenital malaria infection and its detrimental health consequences.
Notes
